Nifty Pharma stocks list
NSESector20 companies
- P/EPrice to earnings of an index. The index's P/E as the exchange publishes it with the close: its members' market value divided by their profit over the last twelve months, each member counted as the index weighs it. Price to earnings of an index: how it is worked out
- 41.20
- P/BPrice to book of an index. The index's P/B as the exchange publishes it: its members' market value divided by their net worth, the assets they own less everything they owe.
- 4.95
- Dividend yieldDividend yield of an index. The index's dividend yield as the exchange publishes it: dividends its members paid over the last twelve months as a percentage of their market value.
- 0.57%
- 1MOne-month return of an index. The latest close against the close a month earlier, on the same date or the last trading day before it, as a percentage. One-month return of an index in the glossary
- −2.72%
- 3MThree-month return of an index. The latest close against the close three months earlier, on the same date or the last trading day before it, as a percentage. Three-month return of an index in the glossary
- +1.24%
- 1YOne-year return of an index. The latest close against the close a year earlier, on the same date or the last trading day before it, as a percentage. One-year return of an index in the glossary
- +17.74%
P/E against its own past
Where today's P/E sits among every trading day of each window: the dot is today, the tick the middle day.
At or below today's level on 81% of 2,478 trading days over the last 10 years.
At or below today's level on 97% of 1,239 trading days over the last 5 years.
At or below today's level on 96% of 743 trading days over the last 3 years.
At or below today's level on 87% of 247 trading days over the last 1 year.
P/E at each month's last trading day, and on 27 Oct 2026
What the Nifty Pharma companies earned
Revenue against the same quarter a year earlier, over today's members that filed both; profit after tax added up over the members that filed the quarter. A quarter fewer than 60% of them filed is left out, and the newest is added once nearly as many have filed it as the one before.
- Revenue growthRevenue growth, against a year earlier. Revenue of the quarter to Jun 2026 against the same quarter a year earlier, added up over the 20 companies that filed both.
- +15.3%quarter to Jun 2026
- ProfitProfit after tax, added up. Profit after tax of the quarter to Jun 2026, added up over the 20 companies that filed it; a loss counts as negative.
- ₹12,721 Crquarter to Jun 2026
- Filed the quarterCompanies that filed the quarter. How many of the index's 20 listed companies have filed results for the quarter to Jun 2026; the revenue growth and the profit are theirs.
- 20of 20
- Median ROCEMedian return on capital employed. The middle figure of the 20 companies' ROCE for the year to Mar 2026, half above and half below. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them.
- 15.8%year to Mar 2026
Revenue against the same quarter a year earlier, per cent
Profit after tax, ₹ crore, added up over the companies that filed
The largest companies
The 12 largest companies in the Nifty Pharma, each sized by its market cap.
Market cap, ₹ crore
- Sun Pharmaceutical Industries₹4,20,172 Cr
- Divi's Laboratories₹2,52,341 Cr
- Torrent Pharmaceuticals₹1,75,920 Cr
- Zydus Lifesciences₹1,16,997 Cr
- Laurus Labs₹1,15,735 Cr
- Dr. Reddy's Laboratories₹1,09,343 Cr
- Cipla₹1,09,063 Cr
- Mankind Pharma₹1,03,365 Cr
- Aurobindo Pharma₹93,643 Cr
- Lupin₹89,263 Cr
- Glenmark Pharmaceuticals₹63,944 Cr
- Alkem Laboratories₹60,715 Cr
Companies in the Nifty Pharma
Largest first, by market cap.Healthcare sector
Sun Pharmaceutical IndustriesSUNPHARMA · Pharmaceuticals & Biotechnology₹1,751.20+0.64%₹4,20,172 Cr34.7016.9%0.91%+3.4%
Divi's LaboratoriesDIVISLAB · Pharmaceuticals & Biotechnology₹9,505.50+5.03%₹2,52,341 Cr86.3020.8%0.32%+46.5%
Torrent PharmaceuticalsTORNTPHARM · Pharmaceuticals & Biotechnology₹4,625.00+1.65%₹1,75,920 Cr82.8012.0%0.82%+28.6%
Zydus LifesciencesZYDUSLIFE · Pharmaceuticals & Biotechnology₹1,172.90+1.08%₹1,16,997 Cr25.9015.9%0.09%+15.7%
Laurus LabsLAURUSLABS · Pharmaceuticals & Biotechnology₹2,142.00+4.04%₹1,15,735 Cr105.9019.8%0.09%+127.8%
Dr. Reddy's LaboratoriesDRREDDY · Pharmaceuticals & Biotechnology₹1,310.00−0.07%₹1,09,343 Cr39.106.0%0.61%+2.0%
Mankind PharmaMANKIND · Pharmaceuticals & Biotechnology₹2,502.50+8.24%₹1,03,365 Cr46.0013.6%None+3.6%
Aurobindo PharmaAUROPHARMA · Pharmaceuticals & Biotechnology₹1,627.50+2.36%₹93,643 Cr25.2011.5%None+48.7%
Glenmark PharmaceuticalsGLENMARK · Pharmaceuticals & Biotechnology₹2,265.70+1.79%₹63,944 Cr35.6039.8%0.11%+25.0%
Alkem LaboratoriesALKEM · Pharmaceuticals & Biotechnology₹5,078.00+0.95%₹60,715 Cr28.1016.5%1.04%−7.3%
Abbott IndiaABBOTINDIA · Pharmaceuticals & Biotechnology₹25,515.00+1.15%₹54,218 Cr33.6039.6%2.57%−14.3%
IPCA LaboratoriesIPCALAB · Pharmaceuticals & Biotechnology₹1,980.80+2.18%₹50,254 Cr38.4017.6%0.30%+52.6%
Ajanta PharmaAJANTPHARM · Pharmaceuticals & Biotechnology₹3,353.60−0.81%₹41,906 Cr36.9027.2%1.79%+40.1%
Sai Life SciencesSAILIFE · Pharmaceuticals & Biotechnology₹1,486.20+2.83%₹31,570 Cr87.3018.7%None+69.2%
Funds that follow the Nifty Pharma
2 index funds and ETFs track the Nifty Pharma.
Nippon India Nifty Pharma ETFETF · Nippon India Mutual FundNAV₹27.00511Y+18.16%3Y+21.71%5Y+13.82%Size₹1,700 CrCost0.23%
ICICI Prudential Nifty Pharma Index FundIndex Fund · ICICI Prudential Mutual FundNAV₹20.33141Y+17.85%3Y+21.29%5Y–Size₹151 CrCost0.51%
About the Nifty Pharma
Nifty Pharma is an index of 20 pharmaceutical companies listed on the National Stock Exchange of India (NSE), maintained by NSE Indices Limited. It captures the performance of the pharmaceutical sector.
How companies are chosen
The index is designed for companies engaged in manufacturing pharmaceuticals and biotechnology, and since Sep 2021 it holds a maximum of 20 stocks.
Companies must form part of the Nifty 500 at the time of review. If fewer than 20 eligible stocks from the sector are in the Nifty 500, the shortfall is filled from the top 800 stocks ranked by both average daily turnover and average daily full market capitalisation over the previous six months.
A company must belong to the pharmaceutical sector, have a trading frequency of at least 90% in the last six months and a listing history of at least 1 month at the cutoff date.
The final 20 are chosen by free-float market capitalization, with a preference for companies available for trading in NSE's Futures & Options segment at the time of final selection.
How it is weighted
Each stock is weighted by its free-float market capitalization, the market value of only the shares available for trading. At the time of rebalancing, no single stock may be more than 33% and the top 3 stocks together may not be more than 62%.
When it is reviewed
The index is rebalanced semi-annually, with cut-off dates of 31 Jan and 31 Jul each year, using average data for the six months ending on the cut-off date.
Base date and value
The index launched on 1 Jul 2005, with a base date of 1 Jan 2001 and a base value of 1000.
- Published by
- NSE
- Kind
- Sector
- CompaniesCompanies in an index. How many companies the index holds on its current list, which the exchange revises from time to time. Companies in an index in the glossary
- 20
- List last changed
- 8 Sep 2026
- Above 200-day averageMembers above their 200-day average. The share of the index's members whose latest close is above their own average close of the last 200 trading days; members listed too recently to have one are left out. Members above their 200-day average in the glossary
- 14 of 20
Sector indices
Others in this group, the most used as a fund's benchmark first.All
- Nifty REITs & Realty15 companiesP/E 51.48
- BSE BANKEX14 companiesP/E 12.18
BSE Financial Services197 companiesP/E 14.66- BSE Insurance13 companiesP/E 23.91
- BSE MidSmall Private Banks18 companiesP/E 14.73
Nifty MidSmall Financial Services30 companiesP/E 17.59
Nifty MidSmall IT & Telecom20 companiesP/E 29.96- Nifty500 Healthcare44 companiesP/E 44.93
BSE Auto21 companiesP/E 31.36
BSE Capital Goods34 companiesP/E 45.79